Ropes & Gray Represents Xeris Biopharma in Global Collaboration, License Agreement With Beta Bionics
May 07, 2024
May 07, 2024
BOSTON, Massachusetts, May 7 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray advised Xeris Biopharma Holdings in an exclusive worldwide collaboration and license agreement with Beta Bionics for the development and commercialization of a glucagon product using Xeris' XeriSol technology for use in Beta Bionics' proprietary bi-hormonal pump and pump systems for people with diabetes. The transaction was announced on May 6.
Under the lice . . .
Ropes & Gray advised Xeris Biopharma Holdings in an exclusive worldwide collaboration and license agreement with Beta Bionics for the development and commercialization of a glucagon product using Xeris' XeriSol technology for use in Beta Bionics' proprietary bi-hormonal pump and pump systems for people with diabetes. The transaction was announced on May 6.
Under the lice . . .